UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Applications of Metabolomics in Oncology: A Review

Clinical cancer research, 2009-01, Vol.15 (2), p.431-440

2009

Volltextzugriff (PDF)

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Journal of clinical oncology, 2010-02, Vol.28 (5), p.780-787

2010

Volltextzugriff (PDF)

A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada

Current oncology (Toronto), 2021-01, Vol.28 (1), p.417-427

2021

Volltextzugriff (PDF)

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer

Case reports in oncology, 2019-09, Vol.12 (3), p.791-795

2019

Volltextzugriff (PDF)

First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Clinical cancer research, 2013-02, Vol.19 (4), p.909-919

2013

Volltextzugriff (PDF)

Looking to the future: biomarkers in the management of pancreatic adenocarcinoma

International Journal of Molecular Sciences, 2011-09, Vol.12 (9), p.5895-5907

2011

Volltextzugriff (PDF)

Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions

Cancers, 2010-12, Vol.2 (4), p.2044-2054

2010

Volltextzugriff (PDF)

The Tumor Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric Adenocarcinoma

Clinical cancer research, 2024-09, p.OF1-OF14

2024

Volltextzugriff (PDF)

Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer

Nutrition in clinical practice, 2019-12, Vol.34 (6), p.922-934

2019

Volltextzugriff (PDF)

Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study

World journal of gastrointestinal oncology, 2023-02, Vol.15 (2), p.303-317

2023

Volltextzugriff (PDF)

Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients

Clinical colorectal cancer, 2016-09, Vol.15 (3), p.257-263

2016

Volltextzugriff (PDF)

Ramucirumab (IMC-1121B): a novel attack on angiogenesis

Future oncology (London, England), 2010-07, Vol.6 (7), p.1085-1094

2010

Volltextzugriff (PDF)

Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta

American journal of clinical oncology, 2018-09, Vol.41 (9), p.867-873

2018

Volltextzugriff (PDF)

Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer

Clinical colorectal cancer, 2018-06, Vol.17 (2), p.156-163

2018

Volltextzugriff (PDF)

Predictive and Prognostic Properties of Human Equilibrative Nucleoside Transporter 1 Expression in Gemcitabine-Treated Pancreatobiliary Cancer: A Meta-Analysis

JCO precision oncology, 2019-12 (3), p.1-22

2019

Volltextzugriff (PDF)

Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma

Canadian liver journal, 2022-11, Vol.5 (4), p.476-492

2022

Volltextzugriff (PDF)

Effects of gender on capecitabine toxicity in colorectal cancer

Journal of oncology pharmacy practice, 2016-06, Vol.22 (3), p.454-460

2016

Volltextzugriff (PDF)

CAPOX Associated With Toxicities of Higher Grade but Improved Disease-Free Survival When Compared With FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer

Clinical colorectal cancer, 2014-09, Vol.13 (3), p.172-177

2014

Volltextzugriff (PDF)

Efficacy and Safety of Single Agent or Combination Adjuvant Chemotherapy in Elderly Patients With Colon Cancer: A Canadian Cancer Institute Experience

Clinical colorectal cancer, 2014-09, Vol.13 (3), p.199-206

2014

Volltextzugriff (PDF)

Retrospective Comparison of CAPOX and FOLFOX Dose Intensity, Toxicity, and Clinical Outcomes in the Treatment of Metastatic Colon Cancer

Journal of gastrointestinal cancer, 2014-06, Vol.45 (2), p.154-160

2014

Volltextzugriff (PDF)

Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer

Investigational new drugs, 2014-10, Vol.32 (5), p.1036-1045

2014

Volltextzugriff (PDF)

Impact of a Dedicated Cancer Center Surveillance Program on Guideline Adherence for Patients With Stage II and III Colorectal Cancer

Clinical colorectal cancer, 2013-06, Vol.12 (2), p.103-112

2013

Volltextzugriff (PDF)

A first-in-human, open-label, phase I trial of daily oral zelenirstat, an NMT inhibitor, in patients with relapsed/refractory advanced cancer including gastrointestinal cancers

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.129-129

2024

Volltextzugriff (PDF)

A 107-gene Nanostring assay effectively characterizes complex multiomic gastric cancer molecular classification in a translational patient-derived organoid model

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4049-4049

2022

Volltextzugriff (PDF)

Targeting metastatic upper gastrointestinal adenocarcinomas

World journal of clinical oncology, 2011-03, Vol.2 (3), p.135-149

2011

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(73)

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Oncology
(23)
Humans
(19)
Male
(14)
Female
(13)
Aged
(12)
Middle Aged
(11)
Adult
(9)
Retrospective Studies
(8)
Neoplasm Staging
(7)
Aged, 80 And Over
(6)
Antineoplastic Agents
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Biological And Medical Sciences
(5)
Chemotherapy
(5)
Deoxycytidine - Analogs & Derivatives
(5)
Gastroenterology And Hepatology
(5)
Hematology, Oncology And Palliative Medicine
(5)
Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical Applications of Metabolomics in Oncology: A Review

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada

Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer

First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Looking to the future: biomarkers in the management of pancreatic adenocarcinoma

Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions

The Tumor Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric Adenocarcinoma

Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer

Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study

Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients

Ramucirumab (IMC-1121B): a novel attack on angiogenesis

Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta

Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer

Predictive and Prognostic Properties of Human Equilibrative Nucleoside Transporter 1 Expression in Gemcitabine-Treated Pancreatobiliary Cancer: A Meta-Analysis

Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma

Effects of gender on capecitabine toxicity in colorectal cancer

CAPOX Associated With Toxicities of Higher Grade but Improved Disease-Free Survival When Compared With FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer

Efficacy and Safety of Single Agent or Combination Adjuvant Chemotherapy in Elderly Patients With Colon Cancer: A Canadian Cancer Institute Experience

Retrospective Comparison of CAPOX and FOLFOX Dose Intensity, Toxicity, and Clinical Outcomes in the Treatment of Metastatic Colon Cancer

Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer

Impact of a Dedicated Cancer Center Surveillance Program on Guideline Adherence for Patients With Stage II and III Colorectal Cancer

A first-in-human, open-label, phase I trial of daily oral zelenirstat, an NMT inhibitor, in patients with relapsed/refractory advanced cancer including gastrointestinal cancers

A 107-gene Nanostring assay effectively characterizes complex multiomic gastric cancer molecular classification in a translational patient-derived organoid model

Targeting metastatic upper gastrointestinal adenocarcinomas

Suchergebnisse filtern